Thu.Feb 02, 2023

article thumbnail

Survey: A majority of Americans support banning all tobacco products

STAT

WASHINGTON — A majority of Americans support banning all tobacco products, according to a new poll published by researchers at the Centers for Disease Control and Prevention. The survey , which was published Thursday in the peer-reviewed journal Preventing Chronic Disease, asked 6,455 people nationwide: “To what extent would you support a policy to prohibit the sale of all tobacco products?

130
130
article thumbnail

Bills Safety Damar Hamlin Launches #3forHeart CPR Challenge

Drug Topics

After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

These blood-clot catching devices have been controversial for years. Why are doctors still relying on them?

STAT

Inferior vena cava filters are supposed to save lives. The spider-like devices catch blood clots before they can travel up to the lung and cause deadly pulmonary embolisms. But for over a decade, these devices have been dogged by questions about how well they work and the serious complications they can cause for patients. The latest data make clear they’re still causing problems: Researchers examined a Food and Drug Administration database and found that adverse event reports related to t

125
125
article thumbnail

US FDA approves GSK’s Jesduvroq to treat anaemia of CKD

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline ’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). It is claimed to be the only HIF-PHI approved in the country that offers a new oral treatment option for adult patients on dialysis with anaemia of CKD.

FDA 105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Eye drops linked to U.S. drug-resistant bacteria outbreak

STAT

NEW YORK — U.S. health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections. The Centers for Disease Control and Prevention on Wednesday night sent a health alert to physicians, saying the outbreak includes at least 55 people in 12 states. One died.

112
112
article thumbnail

2024 DIR Fee Changes

DiversifyRx

What is the DIR Fee Apocalypse? Everything You Need To Know. DIR Fees are the bane of any pharmacy owner. Make sure you are ready for the changes coming in 2024. If you’re a pharmacy owner, you know DIR fees and how they can negatively impact the cash flow of your pharmacy. What many pharmacy owners are not aware of yet, is the DIR changes coming in January 2024.

More Trending

article thumbnail

Magazine: CRISPR gene therapies cut through in 2023

Pharmaceutical Technology

If things go as per plan, in a few months, the US Food and Drug Administration (FDA) will deliberate on the first-of-its-kind CRISPR-based gene therapy for sickle cell disease (SCD) and transfusion-dependent beta thalassemia. Having made significant advances in a relatively short period of time, CRISPR research is now edging closer to reaching the clinic , and this month’s cover story takes a look at the major players in this field and the big events that could break through this year.

FDA 98
article thumbnail

AAM applauds CMS for requiring health plans to place generic drugs on tiers

Drug Store News

The organization publicly commends the administration’s efforts to standardize plan choice by requiring generic drugs be placed on generic tiers and brand-name drugs on brand-name tiers.

98
article thumbnail

Delaying catheter ablation in atrial fibrillation increases the risk of adverse events

Hospital Pharmacy Europe

Increasing the time between catheter ablation and a diagnosis of atrial fibrillation (AF) is associated with worse outcomes for patients both with or without co-existing heart failure, according to an analysis by US researchers. AF is the most clinically significant arrhythmia in practice, affecting between 1 and 3% of the population although this rises to 17% in those 80 years of age and older.

article thumbnail

Opinion: Invasive strep A: bad in affluent countries, far worse in low-income nations

STAT

The deaths of nearly 30 children under the age of 15 years from invasive strep A infections in the United Kingdom between September 2022 and January 2023, together with a rise in new invasive strep A infections in that country, made headlines around the world. In Kenya, about 100 children aged 5 and younger died from invasive strep A infections over the same period — which did not make headlines.

97
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Dr Pepper sweetens beverages with strawberries

Drug Store News

Dr Pepper’s new strawberries and cream beverage features the original 23 signature flavors of the brand, as well as a swirl of strawberry flavors and a creamy finish, the company said.

97
article thumbnail

STAT+: Teva quits brand lobby PhRMA, in line to lead generic lobby AAM

STAT

WASHINGTON  — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has learned.   “ Teva has decided not to renew its membership with PhRMA in 2023,” PhRMA spokesperson Brian Newell confirmed.

93
article thumbnail

Cardinal Health reports revenue growth in Q2

Drug Store News

​​​​​​​Cardinal Health’s second quarter revenue increased 13% to $51.5 billion from the prior year period.

119
119
article thumbnail

Venture capital is investing little in new treatment for addiction, report finds

STAT

There are about as many Americans living with addiction as there are Americans living with cancer — but you wouldn’t know it based on the world of venture capital. In the past decade, investment firms have poured roughly 270 times more money into developing cancer drugs than addiction cures, according to a new report from BIO, the biotechnology industry trade group.

92
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CVS unveils one+other beauty, personal care brand

Drug Store News

CVS’ one+other is a beauty and personal care brand that celebrates self-expression and embraces individuality with more than 200 self-care essentials.

97
article thumbnail

Rare polio case highlights how hard it will be to keep polio gone once it’s eradicated

STAT

An incident that took place at a Dutch polio vaccine production facility late last year is a critical reminder of a major challenge the world faces if and when polio eradication is completed: How do we keep polio from re-establishing itself, given that laboratories and vaccine manufacturers in numerous countries will need to continue to work with the viruses?

article thumbnail

White House unveils CancerX innovation accelerator, new funding for cancer screenings on Moonshot anniversary

Fierce Healthcare

White House unveils CancerX innovation accelerator, new funding for cancer screenings on Moonshot anniversary hlandi Thu, 02/02/2023 - 16:20

98
article thumbnail

Opinion: Generics: a missing piece in China’s Covid-19 crisis response

STAT

China’s massive Covid-19 crisis, sparked in part by the country’s rolling back its strict zero-Covid policies in early December, has seen millions of people infected with SARS-CoV-2. Making the problem worse is that supplies of name-brand Covid-19 drugs are few and far between, and generics of these drugs won’t be available in China due to failed manufacturer negotiations.

86
article thumbnail

First biosimilar to HUMIRA® available in US

European Pharmaceutical Review

AMJEVITA (adalimumab-atto), a biosimilar to Humira ® (adalimumab), is now available in the US. Amgen’s AMJEVITA was the first biosimilar to Humira approved by the US Food and Drug Administration (FDA), in 2016. The active ingredient in the anti-TNF-α monoclonal antibody has the same amino acid sequence as Humira. The Humira biosimilar will be available in prefilled syringe and autoinjector presentations to support dosing in each of the approved indications.

FDA 86
article thumbnail

FTC goes after GoodRx, the controversy around lifesaving devices, and Verily’s future research

STAT

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

article thumbnail

Walmart rolls out new store designs at 5 flagship stores

Drug Store News

Walmart's new look includes brighter lighting, fashionable mannequins, colorful makeup displays, more spacious aisles and pet supplies.

98
article thumbnail

Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro

Fierce Pharma

Amid mainstream hype, Eli Lilly takes a hard line marketing its buzzy diabetes med Mounjaro fkansteiner Thu, 02/02/2023 - 11:20

98
article thumbnail

Payers, providers clash over scope of CMS review of ACA's essential health benefits

Fierce Healthcare

Payers, providers clash over scope of CMS review of ACA's essential health benefits rking Thu, 02/02/2023 - 17:40

104
104
article thumbnail

Pharmapack Europe Awards 2023 winners announced

European Pharmaceutical Review

The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. Three categories were available for entry in the Exhibitor Innovations section. The winning products were: Drug delivery innovation: UniSafe ® reusable connected auto-injector by Owen Mumford Pharmaceutical Services Packaging innovation: PACKSYS GmbH for ampoule dispenser Sustainability initiative: Körber P

article thumbnail

Patients overestimate how well they recall diagnoses, care after discharge: study

Fierce Healthcare

Patients overestimate how well they recall diagnoses, care after discharge: study dmuoio Thu, 02/02/2023 - 16:44

101
101
article thumbnail

Leverage Real Time Location Systems to Achieve Operational Excellence in Biotech Manufacturing

ISPE

Leverage Real Time Location Systems to Achieve Operational Excellence in Biotech Manufacturing Trudy Patterson Thu, 02/02/2023 - 10:00 iSpeak Blog iSpeak Leverage Real Time Location Systems to Achieve Operational Excellence in Biotech Manufacturing 2 February 2023 Most Life Sciences manufacturers face issues while tracking material, equipment, and finished products in one way or another.

article thumbnail

Fierce Pharma Asia—J&J, Legend's CAR-T win; Sanofi's India job cuts; BeiGene, Novartis' PD-1 delay

Fierce Pharma

Fierce Pharma Asia—J&J, Legend's CAR-T win; Sanofi's India job cuts; BeiGene, Novartis' PD-1 delay aliu Thu, 02/02/2023 - 15:58

91
article thumbnail

Bayer, EMD Serono announce 340B restrictions in wake of pharma's courtroom win

Fierce Healthcare

Bayer, EMD Serono announce 340B restrictions in wake of pharma's courtroom win dmuoio Thu, 02/02/2023 - 12:27

98
article thumbnail

Listen: Pharma blockbusters, pandemic policy, & legal chicanery

STAT

Is the next Lipitor on the way? When is a pandemic over-over? And what’s a Texas two-step? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain the looming end of Covid-19’s status as a federal emergency and what that does and doesn’t mean for public health.

75
article thumbnail

CMS seeks to make quality measures more ‘universal’ in rollout of new program

Fierce Healthcare

CMS seeks to make quality measures more ‘universal’ in rollout of new program rking Thu, 02/02/2023 - 11:51

98
article thumbnail

Meijer supports Black Midwestern artists with special product line

Drug Store News

Meijer has rolled out a line of products featuring the art of Dana Powell-Smith, Melina Brann and Shaunt'e Lewis.

96
article thumbnail

GAO: Data on use of Medicare Advantage supplemental benefits are lacking

Fierce Healthcare

GAO: Data on use of Medicare Advantage supplemental benefits are lacking pminemyer Thu, 02/02/2023 - 13:55

98
article thumbnail

La Roche-Posay named fastest growing brand of 2022

Drug Store News

The skin care brand was named the fastest-growing skin care brand of the last year according to NielsenIQ.

97
article thumbnail

Why more granular racial, ethnic data could improve maternal outcomes

Fierce Healthcare

Why more granular racial, ethnic data could improve maternal outcomes fdiamond Thu, 02/02/2023 - 13:51

98